Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-22

Clinical Trial Update: A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intravenous HRS-8427 in adults with complicated urinary tract infection, including acute pyelonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-8427

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) | Phase 2 | Status: UNKNOWN